[1]戴 吉,李泽文,徐义策,等.突发性耳聋患者血清VCAM-1、ENA-78、MMP-2水平变化及检测意义[J].陕西医学杂志,2025,54(2):248-252.[doi:DOI:10.3969/j.issn.1000-7377.2025.02.022]
　DAI Ji,LI Zewen,XU Yice,et al.Changes and detection significance of serum VCAM-1,ENA-78 and MMP-2 levels in patients with sudden deafness[J].,2025,54(2):248-252.[doi:DOI:10.3969/j.issn.1000-7377.2025.02.022]
点击复制

突发性耳聋患者血清VCAM-1、ENA-78、MMP-2水平变化及检测意义
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
54
期数:
2025年2期
页码:
248-252
栏目:
临床检验
出版日期:
2025-02-05

文章信息/Info

Title:
Changes and detection significance of serum VCAM-1,ENA-78 and MMP-2 levels in patients with sudden deafness
作者:
戴 吉; 李泽文; 徐义策; 周 洁; 李兆龙
(孝感市中心医院耳鼻咽喉科,湖北 孝感 432000)
Author(s):
DAI Ji; LI Zewen; XU Yice; ZHOU Jie; LI Zhaolong
(Department of Otolaryngology,the Central Hospital of Xiaogan,Xiaogan 432000,China)
关键词:
突发性耳聋;  血管细胞黏附分子-1;  上皮中性粒细胞活化肽-78;  基质金属蛋白酶-2;  听力损失程度;  预测价值
Keywords:
Sudden deafness;  Vascular cell adhesion molecule-1;  Epithelial neutrophil activating peptide-78;  Matrix metalloproteinase-2;  Degree of hearing loss;  Predictive value
分类号:
R 764.437
DOI:
DOI:10.3969/j.issn.1000-7377.2025.02.022
文献标志码:
A
摘要:
目的:探讨突发性耳聋患者血清血管细胞黏附分子-1(VCAM-1)、上皮中性粒细胞活化肽-78(ENA-78)、基质金属蛋白酶-2(MMP-2)水平变化及检测意义。方法:选取接受治疗的突发性耳聋患者136例为观察组,另选取同期体检健康者136例为对照组。采用ELISA法测定血清VCAM-1、ENA-78、MMP-2水平。根据听力损失程度将患者分为轻度组(46例)、中度组(51例)和重度组(39例)。根据治疗效果将患者分为疗效良好组(82例)和疗效不良组(54例)。比较观察组和对照组血清VCAM-1、ENA-78、MMP-2水平。比较不同听力损失程度及治疗效果患者血清VCAM-1、ENA-78、MMP-2水平。绘制受试者工作特征(ROC)曲线分析血清VCAM-1、ENA-78、MMP-2对突发性耳聋患者疗效不良的预测价值。结果:观察组血清VCAM-1、ENA-78、MMP-2水平高于对照组(均P<0.05)。与轻度组比较,中度和重度组血清VCAM-1、ENA-78、MMP-2水平逐渐升高(均P<0.05)。疗效良好组和疗效不良组患者临床资料比较差异无统计学意义(均P>0.05)。与疗效良好组比较,疗效不良组患者血清VCAM-1、ENA-78、MMP-2水平升高(均P<0.05)。血清VCAM-1、ENA-78、MMP-2三者联合预测突发性耳聋患者疗效不良的AUC高于血清单独指标预测的AUC(均P<0.05)。结论:突发性耳聋患者血清VCAM-1、ENA-78、MMP-2水平升高,与听力损失程度有关,三者联合对突发性耳聋患者治疗效果的预测价值较高。
Abstract:
Objective:To investigate the changes in serum levels of vascular cell adhesion molecule-1(VCAM-1),Epithelial neutrophil activating peptide-78(ENA-78)and matrix metalloproteinase-2(MMP-2)in patients with sudden deafness and the significance of their detection.Methods:A total of 136 patients with sudden deafness treated were selected as the observation group,and 136 healthy individuals from the same period were chosen as the control group.ELISA was used to measure serum levels of VCAM-1,ENA-78,and MMP-2.Patients were divided into mild(46 cases),moderate(51 cases),and severe(39 cases)groups based on the degree of hearing loss.According to the treatment effect,patients were divided into good efficacy group(82 cases)and poor efficacy group(54 cases).Serum levels of VCAM-1,ENA-78 and MMP-2 were compared between the observation and control groups.The levels were also compared among patients with different degrees of hearing loss and treatment effects.The receiver operating characteristic(ROC)curve was plotted to analyze the predictive value of serum VCAM-1,ENA-78,and MMP-2 for poor treatment outcomes in patients with sudden deafness.Results:Serum levels of VCAM-1,ENA-78,and MMP-2 in the observation group were higher than those in the control group(all P<0.05).Compared with the mild group,serum levels of VCAM-1,ENA-78,and MMP-2 gradually increased in the moderate and severe groups(all P<0.05).There was no statistically significant difference in clinical data between patients in the good efficacy group and the poor efficacy group(all P>0.05).Compared with the good efficacy group,serum levels of VCAM-1,ENA-78 and MMP-2 were elevated in the poor efficacy group(all P<0.05).The combined predictive AUC of serum VCAM-1,ENA-78 and MMP-2 for poor treatment outcomes in patients with sudden deafness was higher than that of individual serum markers(all P<0.05).Conclusion:Elevated serum levels of VCAM-1,ENA-78 and MMP-2 in patients with sudden deafness are related to the degree of hearing loss,and their combination has a high predictive value for the treatment outcomes of sudden deafness.

参考文献/References:

[1] LIN W,XIONG G,YAN K,et al.Clinical features and influencing factors for the prognosis of patients with sudden deafness[J].Front Neurol,2022,13(1):1-9.
[2] 程婷,李家荔,程杨丽.突发性耳聋患者预后不良的相关影响因素及预防对策探讨[J].现代医学与健康研究电子杂志,2023,7(23):128-130.
[3] 谢书华,杨竹梅,刘慧茹,等.血浆ET-1、D-D、sVCAM-1、ICAM-1水平预测突发性耳聋患者预后的价值[J].徐州医科大学学报,2024,44(1):32-36.
[4] 吴祎林,李光辉,衡欣.新生血管性青光眼患者房水HGF、ENA78及Sema3A的变化及临床意义[J].海南医学,2024,35(3):385-389.
[5] 李拥军,张佳宁.耳内镜下鼓膜置管术联合盐酸左氧氟沙星滴耳液治疗小儿慢性分泌性中耳炎的效果及对LTD4、IL-5、INF-γ、MMP-2、MMP-9水平的影响[J].临床医学研究与实践,2022,7(16):104-107.
[6] 中华耳鼻咽喉头颈外科杂志编辑委员会,中华医学会耳鼻咽喉头颈外科学分会.突发性聋诊断和治疗指南(2015)[J].中华耳鼻咽喉头颈外科杂志,2015,50(6):443-447.
[7] 余啸,晾波蓓.突发性听力损失的临床诊断与治疗——美国耳鼻咽联头颈外科协会2012版指南意见[J].中国医学文摘-耳鼻咽喉科学,2012,27(6):329-332.
[8] 中华耳鼻咽喉头颈外科杂志编辑委员会,中华医学会耳鼻咽喉头颈外科学分会.突发性聋的诊断和治疗指南(2005年,济南)[J].中华耳鼻咽喉头颈外科杂志,2006,51(8):569-569.
[9] 戴朴,袁永一.耳聋基因诊断与遗传咨询[M].北京:人民卫生出版社,2017:205-208.
[10] 张炜,贾国章,杨斌,等.突发性耳聋患者免疫及血清炎性因子变化及临床意义研究[J].临床误诊误治,2019,32(7):77-80.
[11] 刘国强,郭琳娟,贺阿利,等.放血联合电针治疗突发性耳聋临床研究[J].陕西中医,2024,45(7):980-984.
[12] CAVALLARO G,PANTALEO A,PONTILLO V,et al.Endothelial dysfunction and metabolic disorders in patients with sudden sensorineural hearing loss[J].Medicina(Kaunas),2023,59(10):1718-1729.
[13] 占炜.糖皮质激素联合利多卡因治疗对突发性耳聋患者sVCAM-1水平的影响[J].中国处方药,2020,18(8):134-136.
[14] 章仙芳.掩蔽疗法对突发性耳聋伴耳鸣患者耳鸣情况及血清VCAM-1、HMGB1水平的影响[J].吉林医学,2022,43(3):655-656.
[15] ZHOU T,CHEN M,YUAN Z,et al.Inflammatory markers and the risk of idiopathic sudden sensorineural hearing loss:A Mendelian randomization study[J].Front Neurol,2023,14(1):1-8.
[16] 袁媛,李辉,周卫东.半胱氨酸天冬氨酸蛋白酶3、微小RNA-431和可溶性血管细胞黏附分子-1在突发性耳聋患者血清中的水平变化及其与耳蜗功能相关性研究[J].陕西医学杂志,2024,53(11):1534-1537,1542.
[17] 钟振波,陶静,傅江涛.耳后注射甲泼尼龙琥珀酸钠对2型糖尿病伴突发性耳聋患者听力、血糖和中性粒细胞活化肽-78水平的影响[J].现代实用医学,2022,34(11):1469-1470,1487.
[18] 代浩.血清可溶性血管细胞黏附分子-1在突发性耳聋患者中的水平分析[J].检验医学与临床,2019,16(5):693-695.
[19] 王菁,朱路明,杨冰,等.长春西汀联合巴曲酶对老年2型糖尿病伴耳聋患者听力、血糖及血清visfatin与ENA-78水平的影响[J].实用药物与临床,2021,24(1):48-53.
[20] WIJESUNDARA N M,LEE S F,DAVIDSON R,et al.Carvacrol suppresses inflammatory biomarkers production by lipoteichoic acid- and peptidoglycan-stimulated human tonsil epithelial cells[J].Nutrients,2022,14(3):503-512.
[21] 金涛,周跃飞,王晰,等.血管内皮生长因子、基质金属蛋白酶9、基质金属蛋白酶2与垂体瘤卒中及垂体瘤头痛的关系研究[J].实用心脑肺血管病杂志,2021,29(3):52-57,67.
[22] 苏丽萍,刘郡,王珏.湿房镜联合氟米龙滴眼液治疗干眼症疗效及对患者泪膜稳定性和血清基质金属蛋白酶-2的影响[J].陕西医学杂志,2022,51(5):586-590.
[23] 何善形,张明智,虞华.急性分泌性中耳炎患者耳积液中肿瘤坏死因子-α、一氧化氮、基质金属蛋白酶-2、白细胞介素-10水平与疗效关系研究[J].中国卫生检验杂志,2019,29(12):1488-1490.
[24] 李菁,苏涛,张舜,等.补阳还五汤联合巴曲酶对突发性耳聋患者中医证候、听力水平及血清ET-1、CysC、MMP-2的影响[J].广州中医药大学学报,2023,40(11):2786-2791.
[25] 塞娜,张桐,吴军,等.噪声引起的豚鼠血-迷路屏障损伤及基质金属蛋白酶抑制剂的保护作用[J].中华耳鼻咽喉头颈外科杂志,2020,55(4):8-16.

相似文献/References:

[1]李雅琼,袁国丽.老年突发性耳聋患者听力损失情况及其与血脂水平相关性研究[J].陕西医学杂志,2022,51(7):820.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.012]
　LI Yaqiong,YUAN Guoli.Hearing loss in elderly patients with sudden deafness and its correlation with blood lipid levels[J].,2022,51(2):820.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.012]
[2]袁 媛,李 辉,周卫东.半胱氨酸天冬氨酸蛋白酶3、微小RNA-431和可溶性血管细胞黏附分子-1在突发性耳聋患者血清中的水平变化及其与耳蜗功能相关性研究[J].陕西医学杂志,2024,(11):1534.[doi:DOI:10.3969/j.issn.1000-7377.2024.11.021]
　YUAN Yuan,LI Hui,ZHOU Weidong.Changes in serum levels of Caspase-3,miR-431 and sVCAM-1 in patients with sudden deafness and their correlation with cochlear function[J].,2024,(2):1534.[doi:DOI:10.3969/j.issn.1000-7377.2024.11.021]
[3]张列祥,王协峰,何裕超,等.肿瘤组织微小RNA-542-3p、血管细胞黏附分子-1表达特征与脑胶质瘤术后复发的关系及预测价值[J].陕西医学杂志,2025,54(1):132.[doi:DOI:10.3969/j.issn.1000-7377.2025.01.027]
　ZHANG Liexiang,WANG Xiefeng,HE Yuchao,et al.Relationship and predictive value of miR-542-3p and VCAM-1 expression characteristics in tumor tissues and postoperative recurrence of brain glioma[J].,2025,54(2):132.[doi:DOI:10.3969/j.issn.1000-7377.2025.01.027]

备注/Memo

备注/Memo:
[基金项目]湖北省卫生健康科研立项课题(WJ2021Q015)
更新日期/Last Update: 2025-02-04